Cargando…

Profound thrombocytopenia after primary exposure to eptifibatide

Eptifibatide is a glycoprotein IIb/IIIa receptor antagonist used to reduce the incidence of ischemic events in patients with acute coronary syndromes and those undergoing percutaneous coronary intervention. A minority of patients given eptifibatide develop acute, profound thrombocytopenia (<20,00...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norgard, Nicholas B, Badgley, Brian T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108691/ https://www.ncbi.nlm.nih.gov/pubmed/21701628 http://dx.doi.org/10.2147/DHPS.S13239

Ejemplares similares

Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014)

Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020)

Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021)

Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022)

A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021)

Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery
por: Boettcher, Brent T., et al.
Publicado: (2016)

Metronidazole caused profound drug‐induced immune thrombocytopenia
por: Lew, Jeffrey, et al.
Publicado: (2017)

Eptifibatide-Induced Severe Thrombocytopenia After ST-Elevation Myocardial Infarction (STEMI): A Case Report
por: Gheith, Zaid, et al.
Publicado: (2022)

Lemierre’s syndrome causing profound thrombocytopenia and respiratory failure: a case report: Lemierre’s syndrome with thrombocytopenia
por: Below, Samantha, et al.
Publicado: (2021)

Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
por: Park, Soonyoung, et al.
Publicado: (2013)

Efficacy of intravenous eptifibatide in primary percutaneous coronary intervention patients
por: Jalalian, Rozita, et al.
Publicado: (2021)

Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction
por: Weinreich, Michael, et al.
Publicado: (2014)

Treatment of progressive ischemic stroke with low‑dose eptifibatide: A retrospective case‑control study
por: Luo, Long, et al.
Publicado: (2022)

Profound thrombocytopenia associated with administration of multiple anti‐inflammatory agents in baboons
por: Bikhet, Mohamed H., et al.
Publicado: (2022)

Clinical and economic studies of eptifibatide in coronary stenting
por: Pasala, Tilak, et al.
Publicado: (2014)

Effectiveness and safety of therapeutic plasma exchange to modify the functionality of heparin-induced thrombocytopenia antibodies and correct profound thrombocytopenia: A case report and literature review
por: Graser, Audrey, et al.
Publicado: (2023)

Successful Treatment of a Left Main Thrombus by Intracoronary Eptifibatide Infusion in a 36-Year-Old Patient
por: Alipour-Parsa, Saeed, et al.
Publicado: (2016)

Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy
por: Ha, Christine I., et al.
Publicado: (2017)

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014)

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia
por: Byrne, John, et al.
Publicado: (2015)

Assessment of Eptifibatide Dosing in Renal Impairment Before and After In-Service Education Provided by Pharmacists
por: Donovan, Jennifer L., et al.
Publicado: (2007)

A case of severe thrombocytopenia after the first exposure to rifampicin
por: Nakane, Chinatsu, et al.
Publicado: (2023)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes
por: Shah, Ibrahim, et al.
Publicado: (2010)

How Safe is Eptifibatide during Urgent Carotid Artery Stenting?
por: Allam, Hesham, et al.
Publicado: (2013)

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation
por: Shariati, Hooman, et al.
Publicado: (2016)

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017)

Profound Muscle Weakness and Pain after One Dose of Actonel
por: Badayan, Irina, et al.
Publicado: (2009)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Publicado: (2014)

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells
por: Hajtuch, Justyna, et al.
Publicado: (2022)

Profound Hypoglycemia with Ecstasy Intoxication
por: Carrera, Perliveh, et al.
Publicado: (2015)

A Case of Profound Secretory Diarrhea Revealing 2 Primary Neuroendocrine Tumors
por: Thompson, Ashley A., et al.
Publicado: (2021)

Profound bradycardia associated with NIV removal
por: Echevarria, C., et al.
Publicado: (2011)

Profound Sinoatrial Arrest Associated with Ibrutinib
por: Mathur, Kanupriya, et al.
Publicado: (2017)

Membranous nephropathy associated with profound hypothyroidism
por: Singhania, Girish, et al.
Publicado: (2019)

Remdesivir: Profound bradycardia: case report
Publicado: (2021)

RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect
por: Bardania, Hassan, et al.
Publicado: (2019)

Profound repolarization abnormalities after cylindrical battery ingestion: a case report
por: Huttelmaier, Moritz Till, et al.
Publicado: (2021)

Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction
por: Shemirani, Hasan, et al.
Publicado: (2019)

Profound hyponatremia in cirrhosis: a case report
por: Lindsay, Aaron
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_o9ruf3tcblrtn13b8pp5jl2djg